Home/Filings/4/0001765581-25-000029
4//SEC Filing

Pearce Samantha 4

Accession 0001765581-25-000029

CIK 0001232524other

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 7:00 PM ET

Size

4.8 KB

Accession

0001765581-25-000029

Insider Transaction Report

Form 4
Period: 2025-03-05
Pearce Samantha
EVP, Chief Commercial Officer
Transactions
  • Disposition to Issuer

    Ordinary Shares

    2025-03-05$138.95/sh1,905$264,70041,226 total
Footnotes (1)
  • [F1]Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.

Issuer

Jazz Pharmaceuticals plc

CIK 0001232524

Entity typeother

Related Parties

1
  • filerCIK 0001805688

Filing Metadata

Form type
4
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 7:00 PM ET
Size
4.8 KB